HBIO Projected Dividend Yield
Harvard Bioscience Inc. ( NASDAQ : HBIO )Harvard Bioscience develops, manufactures and sells technologies, products and services that enable fundamental develops in life science applications. Co.'s product families are cellular and molecular technology (CMT) and Preclinical. Co.'s CMT product family includes products supporting research related to molecular, cellular organ and organoid technologies, with additional application in the field of bio-production of pharmaceuticals and therapeutics. Co.'s Preclinical product family includes business lines that support the preclinical research and testing phase for drug development, and in particular testing related to data collection and analysis for safety and regulatory compliance. 20 YEAR PERFORMANCE RESULTS |
HBIO Dividend History Detail HBIO Dividend News HBIO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |